The nonpeptide B2 receptor antagonist FR173657: Inhibition of effects of bradykinin related to its role in nociception

British Journal of Pharmacology

Volumn 124, Issue 6, 1998, Pages 1328-1334

  Griesbacher, Thomas ^a   Amann, Rainer ^a   Sametz, Wolfgang ^b   Diethart, Sabine ^b   Juan, Heinz ^b  

^a UNIVERSITY OF GRAZ   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Bradykinin antagonists; FR173657; Hyperalgesia; Icatibant (Hoe 140); Nociception

Indexed keywords

3 (6 ACETAMIDO 3 PYRIDYL) N [N [2,4 DICHLORO 3 [(2 METHYL 8 QUINOLINYL)OXYMETHYL]PHENYL] N METHYLAMINOCARBONYLMETHYL]ACRYLAMIDE; BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; HYDROCHLORIC ACID; ICATIBANT; PROSTAGLANDIN E2; SUBSTANCE P; TACHYKININ; UNCLASSIFIED DRUG; ANALGESIC AGENT; BRADYKININ B2 RECEPTOR; BRADYKININ RECEPTOR; QUINOLINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HEAT; HYPERALGESIA; LATENT PERIOD; MALE; MUSCLE CONTRACTION; NOCICEPTION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SENSORY NERVE CELL; SPHINCTER PUPILLAE MUSCLE; SUBCUTANEOUS DRUG ADMINISTRATION; TRIGEMINAL NERVE; ANIMAL; ANIMAL BEHAVIOR; BLOOD PRESSURE; DRUG ANTAGONISM; DRUG EFFECT; IN VITRO STUDY; IRIS; PHYSIOLOGY; RABBIT; SPRAGUE DAWLEY RAT;

ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; BLOOD PRESSURE; FEMALE; HEAT; HYPERALGESIA; IRIS; MALE; QUINOLINES; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ;

EID: 0031595092     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701938     Document Type: Article

References (38)

1. ARAMORI, I., ZENKOH, J., MORIKAWA, N O'DONNELL, N., ASANO, M., NAKAMURA, K., IWAMI, M., KOJO, H. & NOTSU, Y. (1997). Novel subtype-selective nonpeptide bradykinin receptor antagonists FR 167334 and FR173657. Mol. Pharmacol., 51, 171-176.
2. 2 receptor antagonist, FR173657. Br. J. Pharmacol., 120, 617-624.
3. BATHON, J.M. & PROUD, D. (1991). Bradykinin antagonists. Ann. Rev. Pharmacol. Toxicol. 31, 129-162.
4. COHEN, S.R, ABBOTT, F.V. & MELZACK, R. (1984). Unilateral analgesia produced by intraventricular morphine. Brain Res., 303, 277-287.
5. DRAY, A. & PERKINS, M.N. (1993). Bradykinin and inflammatory pain. Trends Neurosci., 16, 99-104.
6. DRAY, A. & PERKINS, M.N. (1997). Kinins and pain. In The Kinin System. ed. Farmer, S. pp. 157-172. San Diego: Academic Press.
7. FITZGERALD, M. (1983). Capsaicin and sensory neurons - a review. Pain, 15, 109-130.
8. GEIGY (1982) Scientific Tables Geigy, Vol. 2. Introduction to Statistics. 8th edition. Basle: Ciba-Geigy.
9. GRIESBACHER, T. (1997). Effects of the nonpeptide bradykinin antagonist, FR173657, in experimental models of acute pancreatitis and cystitis in rats. Br. J. Pharmacol. Proc. Suppl., 122, 352P.
10. 2 antagonist, on kinin-induced hypotension, visceral and peripheral oedema formation and bronchoconstriction. Br. J. Pharmacol., 120, 933-939.
11. 2 release, nociceptor stimulation and contraction of the iris sphincter muscle in the rabbit. Br. J. Pharmacol., 92, 333-340.
12. 2 antagonist, on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release. Br. J. Pharmacol., 121, 469-476.
13. GRIESBACHER, T., SUTLIFF, R.L. & LEMBECK, F. (1994). Antiinflammatory and analgesic activity of the bradykinin antagonist, icatibant (Hoe 140), against an extract from Porphyromonas gingivalis. Br. J. Pharmacol., 112, 1004-1006.
14. HALL, J.M. (1992). Bradykinin receptors: pharmacological properties and biological roles. Pharmacol. Ther., 56, 131-190.
15. 2 receptor antagonist WIN 64338 in vivo and in vitro. Br. J. Pharmacol., 116, 3164-3168.
16. HARGREAVES, K., DUBNER, R., BROWN, F., FLORES, C. & JORIS, J. (1988). A new and selective method for measuring thermal nociception in cutaneous hyperalgesia. Pain, 32, 77-88.
17. HITCHINGS, R.A. (1980). The symptom of ocular pain. Trans. Ophthalmol. Soc. U.K., 100, 257-259.
18. HOCK, F.J., WIRTH, K., ALBUS, U., LINZ, W., GERHARDS, H.J., WIEMER, G., HENKE, S., BREIPOHL, G., KÖNIG, W., KNOLLE, J. & SCHÖLKENS, B.A. (1991). Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br. J. Pharmacol., 102, 769-773.
19. HOLZER-PETSCHE, U. (1992). Blood pressure and gastric motor responses to bradykinin and hydrochloric acid injected into somatic or visceral tissues. Naunyn-Schmiedeberg's Arch. Pharmacol., 346, 219-225.
20. JUAN, H. & LEMBECK, F. (1974). Action of peptides and other algesic agents on paravascular pain receptors of the isolated perfused rabbit ear. Naunyn-Schmiedeberg's Arch. Pharmacol., 283, 151-164.
21. KENAKIN, T. (1993). Pharmacologic Analysis of Drug-Receptor Interaction, 2nd ed. New York: Raven Press.
22. KERN, R. (1970). Die adrenergischen Rezeptoren der intraoculären Muskeln des Menschen. Albrecht v. Graefes Arch. Klin. Exp. Ophthalmol., 180, 231-248.
23. LEGAT, F.J., GRIESBACHER, T. & LEMBECK, F. (1994) Mediation by bradykinin of rat paw oedema induced by collagenase from Clostridium histolyticum. Br. J. Pharmacol., 112, 453-460.
24. LEMBECK, F., GRIESBACHER, T., ECKHARDT, M., HENKE, S., BREIPOHL, G. & KNOLLE, J. (1991). New, long-acting, potent bradykinin antagonists. Br. J. Pharmacol., 102, 297-304.
25. 2 receptor antagonist, FR173657, on plasma exudation in rat carrageenin-induced pleurisy. Br. J. Pharmacol., 121, 723-730.
26. MARCEAU, F., LUSSIER, A., REGOLI, D. & GIRAUD, G.P. (1983). Pharmacology of kinins: their relevance to tissue injury and inflammation. Gen. Pharmacol., 14, 209-229.
27. NESS, T.J. & GEBHART, G.F. (1990). Visceral pain: a review of experimental studies. Pain, 41, 167-234.
28. 8]-BK and HOE 140, in two models of persistent hyperalgesia in the rat. Pain, 53, 193-197.
29. PROUD, D. & KAPLAN, A.P. (1988). Kinin formation: mechanisms and role in inflammatory disorders. Ann. Rev. Immunol., 6, 49-83.
30. 2 receptor antagonist; an in vitro study. Hypertension, 29, 951-956.
31. 2 receptor antagonist. Proc. Natl. Acad. Sci. U.S.A., 91, 4693-4697.
32. SCHULIGOI, R., DONNERER, J. & AMANN, R. (1994). Bradykinin-induced sensitization of afferent neurons in the rat paw. Neuroscience, 59, 211-215.
33. STERANKA, L.R., MANNING, D.C., DEHAAS, C.J., FERKANY, J.W., BOROSKY, S.A., CONNOR, J.R., VAVREK, R.J., STEWART, J.M. & SNYDER, S.H. (1988). Bradykinin as a pain mediator: receptors localized to sensory neurons, and antagonists have analgesic actions. Proc. Natl. Acad. Sci. U.S.A., 85, 3245-3249.
34. UEDA, N., MURAMATSU, I. & FUJIWARA, M. (1984). Capsaicin and bradykinin-induced substance P-ergic responses in the iris sphincter muscle of the rabbit. J. Pharmacol. Exp. Ther., 230, 469-473.
35. WIRTH, K.J., HEITSCH, H. & SCHÖLKENS, B.A. (1995). Kinin receptor antagonists: unique probes in basic and clinical research. Can. J. Physiol. Pharmacol., 73, 797-804.
36. WIRTH, K., HOCK, F.J., ALBUS, U., LINZ, W., ALPERMANN, H.G., ANAGNOSTOPOULOS, H., HENKE, S., BREIPOHL, G., KÖNIG, W., KNOLLE, J. & SCHÖLKENS, B.A. (1991). Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies. Br. J. Pharmacol., 102, 774-777.
37. YANOFSKY, N.N. (1988). The acute painful eye. Emerg. Med. Clin. North Am., 6, 21-42.
38. ZAR, J.H. (1984). Biostatistical Analysis. 2nd ed. Englewood Cliffs, N.J.: Prentice-Hall.